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Abstract
Introduction. Indications for the use of cardiac implantable electronic devices (CIEDs) have been expanded over the 
years, just as there has been progress in CIED technology. Open cardiothoracic surgeries have been replaced by transve-
nous procedures conducted with only local anesthesia. These factors have effected certain changes in the quantity, 
proportions, and types of implanted devices. However, it takes a long observation period to determine the direction, 
duration, or rapidity of such trend changes as well as to project the relevant figures for the future.
Material and methods. This retrospective analysis included CIED implantation procedures performed at our center 
in the period from 2002 to 2015. The analyses were based on medical records, including: procedure logs, procedure 
reports, and outpatient follow-up entries. This manuscript includes a year-by-year analysis of selected types of CIED-re-
lated procedures, i.e.: de novo device implantation, device replacement, and device upgrade procedures.
Results. A total of 7,921 CIED-related procedures were conducted in the evaluated period. Female patients consti-
tuted 52% and males 48% (mean age 72.7 years). De novo device implantation procedures constituted 68.5% of all 
CIED-related procedures, device replacement due to predicted battery depletion was conducted in 24.4% of cases, and 
the remaining 7.1% of procedures were classified as ‘other’. The de novo device implantation group involved pacema-
ker (PM) implantation procedures (81.7%) including single-chamber atrial (AAI) (6.2%) and ventricular (VVI) (49.6%) 
devices and dual-chamber atrioventricular (DDD) (43.8%) devices. The remaining 18.3% of the de novo procedures 
were implantable cardioverter-defibrillators (ICD) (83.2%) including dual (ICD-DR) (26.0%) and single-chamber (ICD-VR) 
(57.2%) devices and cardiac resynchronization therapy defibrillators (CRT-D) (16.7%). Single-chamber to dual-chamber 
pacemaker replacement procedures constituted 82.4% of all CIED upgrade procedures. The remaining 17.6% of device 
upgrade procedures included adding new functions, such as terminating ventricular tachyarrhythmias (upgrade to ICD) 
and/or cardiac resynchronization (upgrade to CRT-D).
Conclusions. The general rise in the number of CIED-related procedures saw increasing proportions of ICD and CRT 
device use both in the de novo device implantation and device upgrade groups. Our projections indicate a persistent 
trend of increasing number of CIED-related procedures discussed in this manuscript.
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Introduction
Over the years, indications for the use of cardiac implantab-
le electronic devices (CIEDs) have been gradually expanded: 
from pacemakers (PMs) for the treatment of bradyarrhyth-
mias only, through implantable cardioverter-defibrillators 
(ICDs) designed to prevent sudden cardiac death (SCD) due 
to life-threatening arrhythmias, to cardiac resynchronization 
therapy (CRT) devices for improving systolic function. From 
the time of the earliest procedures, the CIEDs (PMs; ICDs) 
and their components (leads) also underwent technological 
evolution [1–4].
The early, open cardiothoracic procedures with epicar-
dial lead placement evolved towards much less invasive 
procedures with transvenous cardiac lead insertion, which 
require only local anesthesia. The established technique 
used to introduce cardiac leads into the venous lumen via 
dissection and cut-down of either a cephalic (CV) or jugular 
vein was expanded to include axillary vein (AV) or subclavian 
vein (SV) puncture with special lead introducer kits [5–7].
Progressive sinus node and/or atrioventricular node 
dysfunction and/or development of left ventricular systolic 
asynchrony calls for an upgrade in CIED functions. This 
requires a re-intervention to introduce additional leads and 
replace the device with a new one, equipped to manage 
cardiac dysfunction [8, 9].
The expanded indications for CIED implantation, redu-
ced procedure invasiveness, and emergence of new device 
implantation centers have led to increasing numbers of 
CIED-related procedures, also in Poland [10–12].
All these factors effect changes in proportions of 
implanted CIEDs; however, the direction, duration, and 
rapidity of the emerging trends can be observed only over 
longer periods of time. This aspect of chronic electrothe-
rapy prompted us to analyze CIED implantation data in our 
center over a 14-year period.
The objective of this study was to analyze the trends 
in the changes of the CIED types used in a cardiology refe-
rence center over a 14-year period.
Material and methods
The study was a retrospective analysis of CIED-related 
procedures (stratified by groups listed below) performed 
at our cardiology center between the year 2002 and 2015.
We analyzed the data found in medical records: pro-
cedure logs, procedure reports, and follow-up examination 
entries with a particular focus on: patient characteristics 
(age, sex), date and nature of the procedure, and the CIED 
involved.
For the purpose of this manuscript we defined the 
evaluated procedures as follows:
 — device implantation — de novo CIED implantation with 
transvenous cardiac lead insertion;
 — device replacement — elective replacement of the CIED 
(PM, ICD) at the stage of approaching battery depletion 
(elective replacement indicator, ERI);
 — device upgrade — CIED replacement with a device 
with an additional lead to upgrade the function of the 
previous system.
Statistical analyses
The classic method of least squares was used to estimate 
the trend model for the number of procedures performed 
in the period of 2002–2015. The total statistical signifi-
cance of the estimated trend model was calculated with 
the F-test in the analysis of variance and the significance 
of the individual parameters — with Student’s t-test (inclu-
ding the rate of change). The residuals in the estimated 
trend model met the requirements of the classic least 
squares method. Student’s t-test was used to calculate 
the statistical significance of the difference in means. 
The p-values of < 0.05 were considered statistically sig-
nificant. The Bonferroni correction for p-values was used 
for multiple comparisons. For more clarity in the observed 
changes, some figures present the evaluated period divi-
ded into three intervals: 2002–2006, 2007–2010, and 
2011–2015, inclusively.
Results
In the period from January 1, 2002 to December 31, 2015, 
there were a total of 7,921 transvenous CIED-related pro-
cedures conducted at out center. The proportion of female 
patients in the evaluated patient population was 53% (vs. 
47% of males) (mean patient age 72.7 years). Figure 1 
illustrates the quantity of all CIED-related procedures in 
the evaluated period.
De novo device implantation procedures constituted 
68.5% of all CIED-related procedures. Device replacement 
procedures (dictated by ERI) constituted 24.4% of cases 
while the remaining 7.1% of procedures involved other 
procedure types, such as pacing mode change, device 
removal, etc. Figure 2A shows year-by-year quantitative 
data for these types of procedures in the analyzed period, 
with the data-set distribution shown in Figure 2B. The dif-
ferences between mean numbers of these three types of 
procedures in the evaluated period were characterized by 
very low p-values (p < 0.0001 for all comparisons).
Out of 4,395 de novo device implantation procedures 
those that involved PM implantation constituted 81.7%, 
including 6.2% of atrial pacing (AAI), 49.6% of ventricular 
pacing (VVI), and 35% of atrioventricular pacing (DDD) 
device implantation procedures. The proportion of cardiac 
pacing device types implanted over the last 14 years has 
changed. This includes a decrease in single-chamber 
(VVI-mode) devices (59% → 46% → 41%) in favor of double-
-chamber (DDD-mode) devices (31% → 49% → 55%). 
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Figure 3 illustrates the proportions of these types of pro-
cedures in the analyzed period.
There is a substantial qualitative change involving an 
increase in double-chamber DDD system implantation with 
the corresponding decrease in AAI and VVI system implan-
tation procedures observed over time. In the subgroup 
of DDD system implantation procedures the quantitative 
increases observed in the predetermined intervals were 
statistically significant, especially in the recent years 
(p < 0.0001). This finding corresponded to a decrease 
in single-chamber system implantation in the same time 
periods (p < 0.0001 for VVI).
Out of all 990 de novo non-PM CIED implantation pro-
cedures those involving ICDs constituted 81.7% (including 
ICD-DR 26.0%, ICD-VR 57.2%) and those involving cardiac 
resynchronization therapy-defibrillator (CRT-D) devices 
constituted 16.7%.
The incidences of these types of procedures in the 
evaluated time periods are presented in Figure 4. The 
ICD group shows an increase in the numbers of ICD-VR 
implantation procedures from those recorded in the period 
of 2002–2006 to those in 2007–2010 (p < 0.0366) as 
well as from those recorded in 2002–2006 to those in 
2011–2015 (p < 0.0001).
Irrespective of the consistently considerable propor-
tion of ICD-VR implantation procedures, we observed 
an increase in dual-chamber ICDs combining ventricular 
tachyarrhythmia therapy with ventricular and atrial pacing 
and sensing (ICD-DR), with the p-value < 0.0328 (for 
2011–2015 vs. 2002–2006). In the case of CRT-D de-
vice implantation procedures the quantitative changes 
were similar to those observed for ICD-DR devices, with 
a significant increase in the number of procedures con-
ducted in 2011–2015 vs. those conducted in 2002– 
–2006 (p < 0.0148).
As shown in Figure 5, CRT-pacemakers (CRT-P) consti-
tuted 66% of the 53 rarely performed procedures involving 
the implantation of biatrial (BiAAI), biventricular (BiVVI), 
biatrial/right-ventricle (BiADDD), and left-atrium (1 LAAI 
system, not illustrated graphically) pacing systems.
Figure 1. Quantitative distribution of all CIED-related procedures conducted at the center in 2002–2015 along with estimated future figures 
(with a 95% confidence interval for the predicted values)
Figure 2A. Quantitative distribution in the three identified procedure subtypes performed in 2002–2015; B. Box-plot showing the data-set 
distribution
A B
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Lead revision procedures involving new cardiac lead 
placement without inactive lead extraction, but not 
involving device replacement, constituted 1% of all ana-
lyzed procedures. Indications for these procedures were 
mechanical damage to the insulation or the conductor 
wire or increased stimulation threshold. In this type of 
procedures the original mode of electrotherapy remained 
unchanged.
PM upgrade procedures (n = 168) constituted 82.4% 
of all device upgrade procedures. This subtype of device 
upgrade procedures involved adding a new cardiac lead 
and replacing the existing pacemaker with one that offered 
more pacing mode options (Figure 6A).
Device upgrade procedures involving introduction of 
a system with new functions, such as ventricular arrhythmia 
termination (ICD device) or cardiac resynchronization (CRT-D) 
constituted 17.6% of all upgrade procedures. Figure 6B 
illustrates the marked emergence of device upgrades to 
ICD-DR and CRT-D.
Discussion
The analyzed 14-year period shows a growing trend in the 
numbers of CIED-related procedures, which allowed us to 
predict the projected future figures for procedures of the 
same type. However, we observed a change in proportions 
Figure 3A. Quantitative distribution of de novo AAI, VVI, DDD, and VDD system implantation procedures in three time periods spanning the 
evaluated 14-year interval (2002–2015); B. Box-plot showing the data-set distribution
A B
Figure 4A. Quantitative distribution of ICD (ICD-DR, ICD-VR) and CRT-D device implantation procedures in three time periods spanning the 
evaluated interval (2002–2015); B. Box-plot showing the data-set distribution
A B
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between the de novo device implantation, device replace-
ment (dictated by ERI), and other CIED-related procedures.
The de novo device implantation procedures showed 
pronounced, reverse changes in proportion involving 
a growing number of dual-chamber atrioventricular (DDD) 
systems with a simultaneously diminishing number of 
single-chamber systems. This seems to be associated with 
the indications for DDD-mode device implantation being 
followed more accurately (according to the established 
standards), particularly when it comes to the elderly. Mo-
reover, the introduction of screw-in leads, which ensure 
a more secure atrial lead placement (as opposed to tined 
leads), has contributed to higher rates of atrioventricular 
pacing devices being implanted, even in cases presenting 
anatomical or electrophysiological challenges.
The surge in the number of device replacement proce-
dures at our center in the recent years seems to be due to 
an overlap in the ERI phases of two types of devices: PMs 
(which are characterized by a long battery life) implanted 
over 10 years ago and ICDs, with a considerably shorter 
battery life, implanted several years ago. The last several 
years saw an increase in ICD implantation procedures.
The steady increase in the number of implanted CRT-D 
devices, which combine the antiarrhythmic function with 
left ventricular asynchrony management, was similar to that 
observed among ICD-DR device implantation procedures. 
The group of rarely implanted CIED types featured mainly 
CRT-P devices.
The quantitative decrease in lead revision procedures 
involving new cardiac lead placement without inactive lead 
extraction seems to be, at least partly, due to continual 
technological and material advances.
The majority of PM upgrade procedures involved de-
vices offering atrioventricular block treatment options. 
These PM replacement procedures with a cardiac lead 
addition involved either a ventricular lead being added to 
the already implanted atrial lead in atrial pacing devices 
(AAI → DDD) as it became indicated by a developed sinus 
Figure 5A, B. Procedures involving rare pacing systems conducted in 2002–2015
A B
Figure 6A. Pacing system upgrade procedures conducted in 2002–2015; B. Pacing system upgrade procedures to ICD or CRT systems 
conducted in 2002–2015
A B
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node dysfunction, or it was an atrial lead (VVI → DDD) that 
was added due to pacemaker syndrome in patients with 
pre-existing ventricular pacing.
The device upgrade group demonstrated a noticeably 
increasing proportion of pacemakers, which offer only 
a simple pacing function, being replaced with ICD and/or 
CRT devices. This phenomenon can be linked to the natural 
heart disease progression involving sinus node dysfunction 
and/or left ventricular systolic dysfunction in patients 
already implanted with conventional permanent cardiac 
pacing devices (typically in their 80 s).
The presented tendencies in qualitative and quantita-
tive changes involving CIED-related procedures are similar 
to those observed in other centers in Poland and in other 
countries [10–12].
Conclusions
The analyzed period of time demonstrated an increase in 
both the general number of CIED-related procedures and 
the proportion of ICD and/or CRT devices in de novo and 
upgrade procedures.
The projected future figures suggest continued increase 
in the number of procedures involving the CIEDs analyzed 
in this manuscript.
Limitations
One limitation of this study was the fact that the changes 
in the type and number of implanted CIED were analyzed 
based on data from procedure reports. Such reference 
materials introduce a certain number of errors, e.g. altering 
the indications for implanting a particular device based on 
the technical feasibility of performing a given procedure.
Nonetheless, considering the long, 14-year, period of 
observation and the sheer number of total procedures, we 
do not believe such instances should noticeably affect the 
presented trends. For similar reasons a detailed analysis of 
rarely used cardiac electrotherapy devices was not included 
in this manuscript.
Streszczenie
Wstęp. Wskazania do stosowania kardiologicznych wszczepialnych urządzeń elektronicznych (CIED) przez lata się 
rozszerzyły, a także dokonała się ewolucja rozwiązań technologicznych implantowanych urządzeń. Operacje torako-
kardiochirurgiczne ustąpiły miejsca technikom zabiegowym z wykorzystaniem układu żylnego i wykonywanym w tylko 
miejscowym znieczuleniu. Wszystkie te czynniki łącznie modelują zmianę liczby i proporcji oraz rodzajów urządzeń im-
plantowanych podczas procedur. Ukierunkowanie, trwałość lub dynamika zmian trendów są jednak widoczne dopiero 
w dłuższych okresach, co jednocześnie pozwala na szacowanie wartości prognostycznych.
Materiał i metody. Oceną retrospektywną objęto zabiegi CIED wykonane w ośrodku w latach 2002–2015. Analizę 
badanego materiału przeprowadzono z wykorzystaniem informacji zawartych w dokumentacji medycznej, w tym w księ-
gach zabiegowych i protokołach wykonanej procedury, oraz zaczerpnięto z przeprowadzonych poszpitalnych badań 
kontrolnych. W opracowaniu uwzględniono coroczną analizę wyodrębnionych grup zabiegów, takich jak implantacje 
pierwszorazowe (de novo), wymiany urządzeń, modernizacje (up-grade).
Wyniki. W badanym okresie przeprowadzono łącznie 7921 zabiegów z zakresu CIED. Stosunek odsetków kobiet do 
mężczyzn wynosił 52% v. 48% (śr. wieku: 72,7 roku).
Implantacje de novo stanowiły 68,5% wszystkich wykonanych procedur, wymiany urządzeń z powodu wyczerpywania 
się baterii zasilających dotyczyły 24,4% przypadków, a 7,1% stanowiły pozostałe zabiegi. W grupie pierwszorazowych 
procedur wszczepienia stymulatorów (PM) dotyczyły 81,7% zabiegów, w tym: przedsionkowych (AAI) — 6,2%, komoro-
wych (VVI) — 49,6%, przedsionkowo-komorowych (DDD) — 43,8%. Pozostałe 18,3% procedur de novo tworzyły w 83,2% 
układy kardiowertująco-defibrylujące (ICD), w tym w 26,0% — ICD-DR, w 57,2% — ICD-VR, a w 16,7% — wzbogacone 
o funkcję resynchornizacji CRT-D. Modernizacje w obrębie układów stymulujących objęły 82,4% wszystkich zabiegów 
o charakterze up-grade. Zabiegi up-grade wzbogacające dotychczasowy układ o urządzenie z nowymi funkcjami, taki-
mi jak przerywanie tachyarytmii komorowych (do → ICD) i/lub resynchronizację serca (do → CRT-D), stanowiły 17,6% 
wszystkich modyfikacji.
Wnioski. Wzrostowi ogólnej liczby wykonywanych zabiegów CIED towarzyszyło zwiększanie udziału zakładanych urządzeń 
z rozszerzonym zakresem terapii o funkcje antyarytmiczne i/lub resynchronizujące zarówno w grupach zabiegów de 
novo, jak i up-grade. Szacowane wartości prognostyczne wskazują na utrzymanie się trendu wzrostu liczby wykonywania 
procedur CIED z urządzeniami analizowanych w opracowaniu.
Słowa kluczowe: wszczepialne kardiowertery-defibrylatory, stymulatory serca, badanie retrospektywne
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